Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
National Institutes of Health Clinical Center (CC)
Children's Hospital of Philadelphia
Pierre Fabre Medicament
Virtual Tribunal Monastery
Washington University School of Medicine
Scripps Translational Science Institute
Columbia University
Roswell Park Cancer Institute
Sumitomo Pharma Switzerland GmbH
CHU de Reims
Meyer Children's Hospital IRCCS
National Institutes of Health Clinical Center (CC)
Cairo University
Children's Cancer Group, China
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Columbia University
New York Medical College
Johann Wolfgang Goethe University Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Ann & Robert H Lurie Children's Hospital of Chicago
National Institutes of Health Clinical Center (CC)
Columbia University
National Institutes of Health Clinical Center (CC)